论文信息 - Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate. - 字舞流文

Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.

P. Loria | D. Hepworth | S. Bhattacharya | H. Gao | K. McClure | K. Lapham | V. M. Jackson | Jigna D. Patel | G. Storer | K. O. Cameron | Ramsay E. Beveridge | D. Fernando | M. Vanvolkenburg | R. Kosa | Colin R. Rose | Chi-Li Chen | Vishal Khot | I. Stock | James E. Saenz | K. Cameron | J. Kong | Guoqiang Wang | Jun Xiao | Allyn T. Londregan | M. Dunn | D. Vrieze | K. Andrews | Yingxin Zhang | S. T. M. Orr | Hua Gao | Hua Gao | Suvi T. M. Orr | Kimberly O. Cameron | V. Jackson | Kim F. McClure